Advertisement

Behavioral Health

Acadia CFO exits, execs split on psychedelics as parity, Medicaid pressures mount April 27, 2026 1. FDA backs 3 psychedelic drug studies for mental illness Full story 2. Acadia taps interim CFO amid finance chief's departure Full story 3. CommonSpirit,…

Psilocybin, GLP-1s, marijuana policy and more BH updates April 23, 2026 1. What is psilocybin? Inside Trump's push for psychedelic treatments Full story 2. 'It buys patients time': GLP-1s show early promise in addiction treatment Full story 3. Data isn't…

Advertisement

HHS backs new therapies as access tightens, care models evolve April 22, 2026 1. HHS agency launches $139.4M behavioral health research initiative Full story 2. Autism care provider closes New York Medicaid panels after rate cuts Full story 3. Behavioral…

What BH leaders need to know on ibogaine, safety risks, new research and a major nonprofit merger April 21, 2026 1. What is ibogaine? 4 things to know Full story 2. Psych hospital's security change draws scrutiny amid patient assaults Full…

Federal push on psychedelics, AI oversight gains steam as parity scrutiny intensifies April 20, 2026 1. Trump order fast-tracks psychedelics for mental illness: 4 notes Full story 2. 5 states regulating AI in mental health Full story 3. What if…

Behavioral health demand rises as access, coverage pressures grow April 16, 2026 1. Wider care gaps predicted as mental health parity rule faces rollback Full story 2. Mental health ED visits at Children's Hospital Colorado jump 20% in April Full…

Workforce gaps, access expansions shape behavioral health care April 15, 2026 1. 'Mini specialists': 5 models reshaping behavioral health in primary care Full story 2. 5 new university programs tackling behavioral health workforce gaps Full story 3. Manual RCM work…

Advertisement